IonQ details severance terms for former CFO Thomas Kramer

IonQ, Inc. filed an amended current report to add details of the separation agreement with its former Chief Financial Officer, Thomas Kramer.

Rhea-AI Filing Summary

IonQ, Inc. filed an amended current report to add details of the separation agreement with its former Chief Financial Officer, Thomas Kramer. The amendment explains that, under the company’s executive severance plan and his performance-based equity award, Kramer will receive a lump-sum cash severance equal to nine months of base salary, his full 2025 target bonus and an additional pro-rated 2025 bonus for the period he worked, payable after his release of claims becomes effective.

IonQ will also cover his health insurance premiums under COBRA for up to nine months if he elects continuation coverage. All of his unvested restricted stock units and certain unvested stock options will fully vest, while remaining unvested options will be forfeited, and his performance stock units will vest at target, adjusted for the portion of the performance period he served. The amendment does not change other disclosures in the original report.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does IonQ (IONQ) disclose in this 8-K/A amendment?

The amendment describes the material terms of the separation agreement with former CFO Thomas Kramer, including his cash severance, bonus treatment, benefits, and equity vesting.

What cash severance will former IonQ CFO Thomas Kramer receive?

Thomas Kramer is entitled to a lump-sum cash payment equal to nine months of base salary, 100% of his 2025 annual target bonus, and a pro-rated portion of his 2025 target bonus based on days worked.

How will IonQ handle health benefits for former CFO Thomas Kramer?

If he elects COBRA continuation coverage, IonQ will pay the COBRA premiums for up to nine months following the end of his employee coverage.

What happens to Thomas Kramer’s IonQ equity awards after his departure?

All of his unvested restricted stock units and certain stock options will fully vest, remaining unvested options will be forfeited, and his performance stock units will vest at target, prorated for the time he provided services.

Which agreements govern Thomas Kramer’s severance from IonQ (IONQ)?

His severance terms are based on IonQ’s Amended and Restated Executive Severance Plan, his performance-based restricted stock unit award agreement, and the December 2, 2025 Separation Agreement.

Does this IonQ 8-K/A change other information from the original report?

No. The amendment is filed solely to add the separation agreement terms for Thomas Kramer and does not modify other disclosures from the original report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/05/2025 - 05:25 PM EST Learn about SEC filing dates

true00018249200001824920ionq:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerShareMember2025-09-022025-09-0200018249202025-09-022025-09-020001824920ionq:CommonStockParValue00001PerShareMember2025-09-022025-09-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 02, 2025

IonQ, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-39694	85-2992192
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
4505 Campus Drive
College Park, Maryland				20740
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 301 298-7997

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.0001 per share		IONQ		New York Stock Exchange
Warrants, each exercisable for one share of common stock for $11.50 per share		IONQ WS		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Explanatory Note

IonQ, Inc. (the "Company") is filing this Amendment No. 1 to its Current Report on Form 8-K filed with the Securities and Exchange Commission on September 4, 2025 (the "Original Report") solely for the purpose of disclosing the material terms of the separation agreement and release of claims that the Company entered into with Thomas Kramer, the Company's former Chief Financial Officer, on December 2, 2025. Other than as set forth in this Explanatory Note, this Amendment No. 1 does not amend any other disclosures in the Original Report.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Kramer Separation

As a result of his departure, Mr. Kramer will qualify for certain benefits under the Company’s Amended and Restated Executive Severance Plan (the “Executive Severance Plan”) and his performance-based restricted stock unit (“PSU”) award agreement (the “PSU Award Agreement”). Accordingly, on December 2, 2025, the Company and Mr. Kramer entered into a Separation Agreement (the “Kramer Separation Agreement”) including a release of claims in favor of the Company and, as such, he will be eligible to receive the following payments and benefits:

•Cash Severance: A gross cash payment, less applicable withholdings and deductions, equal to (i) nine months of base salary, (ii) 100% of his 2025 annual target bonus and (iii) a portion of his 2025 annual target bonus, pro-rated to the number of days worked as an employee in 2025, which gross payment will be made in a lump sum within 30 days after the release of claims becomes effective.

•COBRA Benefits: If Mr. Kramer elects to receive continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, the Company will pay the applicable premiums for him for up to nine months following the termination of his coverage as an employee.

•Equity Vesting: All of Mr. Kramer’s unvested restricted stock units will accelerate and become vested in full, certain unvested stock options held by Mr. Kramer will accelerate and become vested in full, with any unvested stock options being forfeited for no consideration, and his PSUs will vest, based on target performance, prorated for the portion of the performance period during which he provided services to the Company.

The foregoing summary of Mr. Kramer’s severance entitlements is not a complete discussion of those terms and is qualified in its entirety by reference to the full text of the Executive Severance Plan and the PSU Award Agreement, copies of which are filed as Exhibits 10.2 and 10.9 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and are incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			IonQ, Inc.
Date:	December 5, 2025	By:	/s/ Paul T. Dacier
			Paul T. Dacier Chief Legal Officer and Secretary